Modulation of CD103 expression on human colon carcinoma-specific CTL

Khoon-Lin Ling1, Nicolas Dulphy, Pru Bahl

  • 1Tumor Immunology Group, Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.

Summary

Tumor-infiltrating T cells improve survival in colorectal cancer. This study shows TGF-beta1 and antigen recognition during T cell priming upregulate CD103/beta7, enhancing T cell retention in tumors.